Brief: Novonesis Increases Outlook For 2024

Novozymes A/S

27/08/2024 15:32

Aug 27 (Reuters) - Novozymes A/S  NSISb.CO :
    * NOVONESIS INCREASES OUTLOOK FOR FULL YEAR 2024
    * INCREASES ITS FULL-YEAR SALES AND PROFITABILITY OUTLOOK
BASED ON
FIRST HALF YEAR PERFORMANCE COUPLED WITH STRONG MOMENTUM GOING
INTO FIRST MONTHS OF SECOND HALF
    * 2024 PRO FORMA ADJUSTED EBITDA MARGIN OF NOW 35.5-36.5%
(PREVIOUSLY "35-36%")
    * 2024 OUTLOOK IS INCREASED TO: PRO FORMA ORGANIC SALES
GROWTH OF
NOW 7-8% (PREVIOUSLY "UPPER END OF 5-7%")

Source text for Eikon:  ID:nGNE2gTpcJ 
Further company coverage:  NSISb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))